Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06429982 · ClinicalTrials.gov registry record · Phase 1
Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols
A Phase 1 study of Rhabdomyolysis, sponsored by Children's National Research Institute.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06429982 is a Phase 1 study of Rhabdomyolysis that is actively recruiting participants, run by Children's National Research Institute. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06429982, a Phase 1 study of Rhabdomyolysis, is actively recruiting participants, sponsored by Children's National Research Institute.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
There is a significant unmet need for optimized treatment in rhabdomyolysis. There are few prospective interventional studies on treatment for rhabdomyolysis, a condition which affects diverse and underrepresented populations at a higher rate. While steroids are often used off-label, a systematic study has not yet been initiated, and steroids have not been yet considered in as a consideration to standard care guidelines. The hypothesis is that patients who receive dexamethasone in addition to standard care versus placebo and standard care will have improvement in pain, length of hospital stay, and decrease in kidney complications.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Dexamethasone
Study Locations (1)
District of Columbia
- Childrens National - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06429982
The ClinicalTrials.gov registry entry for NCT06429982 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's National Research Institute, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Rhabdomyolysis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06429982 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06429982 about?
NCT06429982 is a clinical study titled "Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols". There is a significant unmet need for optimized treatment in rhabdomyolysis. There are few prospective interventional studies on treatment for rhabdomyolysis, a condition which affects diverse and underrepresented populations at a higher rate. While steroids are often used off-label, a systematic st...
What is the current status of trial NCT06429982?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2024-10-01. Estimated completion is 2026-12-31.
What conditions does trial NCT06429982 study?
This clinical trial studies the following conditions: Rhabdomyolysis.
What interventions are being tested in trial NCT06429982?
The interventions under investigation include: Placebo (DRUG), Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT06429982?
This trial is sponsored by Children's National Research Institute, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06429982 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rhabdomyolysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.